Durable Complete Response to AMG 655 (Conatumumab) and Vorinostat in a Patient With Relapsed Classical Hodgkin Lymphoma: Extraordinary Response from a Phase 1b Clinical Protocol

Lymphoma
24/08/2020

Clin Lymphoma Myeloma Leuk. 2020 Jul 25:S2152-2650(20)30373-6. doi: 10.1016/j.clml.2020.07.012. Online ahead of print.

NO ABSTRACT